Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy van de Sande

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Discovery|May 25, 2022
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approachWilson Lim, Annelies Verbon, Wendy van de Sande
International Journal of Molecular Sciences|August 28, 2025
Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug AuranofinJingyi Ma, Wendy van de Sande, Bernhard Biersack
Plos Neglected Tropical Diseases|August 25, 2017
Mycetoma laboratory diagnosis: Review articleAmel Altayeb Ahmed, Wendy van de Sande, Ahmed Hassan Fahal
Tropical Medicine & International Health : TM & IH|June 25, 2013
Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese populationNajwa Mhmoud, Ahmed Fahal, W J Wendy van de Sande
Journal of Clinical Microbiology|February 17, 2012
Secondary peritonitis caused by Streptomyces viridisPriya Datta, Shilpa Arora, Ruby Jain, et al.
Journal of Clinical Microbiology|October 9, 2003
Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonalAbdalla Ahmed, Wendy van de Sande, Henri Verbrugh, et al.
Plos Neglected Tropical Diseases|March 14, 2015
The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agentHassabelrasoul Elfadil, Ahmed Fahal, Wendy Kloezen, et al.
Journal of Clinical Microbiology|November 6, 2004
An unexpected experimental pitfall in the molecular diagnosis of bacterial endophthalmitisLuana Ugahary, Wendy van de Sande, Jan C van Meurs, et al.
Tropical Medicine & International Health : TM & IH|March 26, 2017
Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatisKimberly Eadie, Florianne Parel, Marilyn Helvert-van Poppel, et al.
Medical Mycology Case Reports|August 18, 2025
<i>Madurella tropicana</i> and <i>Madurella pseudomycetomatis</i> identified as new causative agents of black grain eumycetoma in SenegalMaguette Faye, Maodo Ndiaye, Abdou Magib Gaye, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Discovery|May 25, 2022
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approachWilson Lim, Annelies Verbon, Wendy van de Sande
International Journal of Molecular Sciences|August 28, 2025
Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug AuranofinJingyi Ma, Wendy van de Sande, Bernhard Biersack
Plos Neglected Tropical Diseases|August 25, 2017
Mycetoma laboratory diagnosis: Review articleAmel Altayeb Ahmed, Wendy van de Sande, Ahmed Hassan Fahal
Tropical Medicine & International Health : TM & IH|June 25, 2013
Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese populationNajwa Mhmoud, Ahmed Fahal, W J Wendy van de Sande
Journal of Clinical Microbiology|February 17, 2012
Secondary peritonitis caused by Streptomyces viridisPriya Datta, Shilpa Arora, Ruby Jain, et al.
Journal of Clinical Microbiology|October 9, 2003
Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonalAbdalla Ahmed, Wendy van de Sande, Henri Verbrugh, et al.
Plos Neglected Tropical Diseases|March 14, 2015
The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agentHassabelrasoul Elfadil, Ahmed Fahal, Wendy Kloezen, et al.
Journal of Clinical Microbiology|November 6, 2004
An unexpected experimental pitfall in the molecular diagnosis of bacterial endophthalmitisLuana Ugahary, Wendy van de Sande, Jan C van Meurs, et al.
Tropical Medicine & International Health : TM & IH|March 26, 2017
Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatisKimberly Eadie, Florianne Parel, Marilyn Helvert-van Poppel, et al.
Medical Mycology Case Reports|August 18, 2025
<i>Madurella tropicana</i> and <i>Madurella pseudomycetomatis</i> identified as new causative agents of black grain eumycetoma in SenegalMaguette Faye, Maodo Ndiaye, Abdou Magib Gaye, et al.
Pageof 3